We welcomed OPTUS Pharma, a leading Korean Ophthalmology company, team to SanderStrothmann Headquarters in Germany. The visit provided an opportunity for SanderStrothmann to showcase the depth and breadth of our expertise in fulfilling OPTUS Pharma’s cosmeceutical and nutraceutical product pipeline strategy.

The OPTUS Pharma team was given a comprehensive tour of SanderStrothmann’s state-of-the-art facility, where they were introduced to the cross-functional team responsible for the successful research, development and production of cosmeceutical and nutraceutical products. The team members demonstrated their expertise in various areas such as research and development, formulation, manufacturing, quality control, regulatory and compliance.

Ms. Park Eun Young, CEO of OPTUS Pharma, expressed her gratitude to the SanderStrothmann team for the warm welcome and the market insights shared during the visit. She also commended SanderStrothmann’s team for their expertise and dedication to their work. This visit greatly strengthened the collaboration and trust between SanderStrothmann and OPTUS Pharma.

The visit was marked with a Memorandum of Understanding signing ceremony, where the teams from OPTUS Pharma and SanderStrothmann committed to exchange innovative ideas on product concept, science-based formulation and packaging ideas. The visit was a testament to SanderStrothmann’s commitment to excellence in serving its collaborators and its role as a trusted partner to the healthcare industry.

In conclusion, the visit by the OPTUS Pharma leadership team to SanderStrothmann’s headquarters provided an excellent opportunity for both teams to learn from each other and boost our collaborative plans.